Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Ghana

Global PrEP Tracker
Last Updated: 5 March 2025

Drug Registration Status

Approved
Pending
Not
Approved
Lenacapavir (LEN) for PrEP — Gilead
Cabotegravir (CAB) for PrEP — ViiV
Not Approved
Dapivirine Vaginal Ring (DVR) — Pop Council
Under Review
Oral PrEP TDF/xTC* — Gilead (Truvada)
Approved N/A N/A
Oral PrEP TDF/xTC — generic
Approved N/A N/A
Oral PrEP F/TAF — Gilead
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

N/A Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

N/A Planned/Ongoing Projects

Policy Frameworks

Ghana National HIV/AIDS Policy, 2019

Ghana National HIV/AIDS Strategic Plan, 2021-25

Est. Cumulative
Initiations:

Total PrEP: 15,574

Oral PrEP: 15,574

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Featured Resources

Document

West Africa Region ROP, 2022

The goal of the 2022 West Africa Region Regional Operational Plan is to maintain progress from 2021 in key areas related to health promotion such as refining efforts to eliminate policy barriers, insitutionalizing client- centered services, helping the country achieve 95-95-95, and spotlighting HIV prevention and treatment access for all populations in need.
View All Resources